A new study published today in Nature Communications shows a promising alternative for those who have to take a daily pill regimen. Targeting HIV treatment and prevention, researchers across multiple departments at the University of North Carolina at Chapel Hill collaborated on a seven-year study in animals to make a better injectable drug implant that can combine multiple drugs and is ultra-long-acting, while also addressing many of the challenges faced with current HIV treatment and prevention methods.
“There is no FDA-approved or marketed technology for long-acting prevention of HIV, and we are the first to use this delivery method with multiple antiretroviral drugs,” said Rahima Benhabbour, PhD, MSc, first author of the study and assistant professor in the UNC_NCSU Joint Department of Biomedical Engineering. “To have an HIV prevention treatment that consists of an injection once or twice a year would make an incredible impact for patients.” She added, “This technology is not only promising for HIV, but for any kind of condition that requires a daily intake of medication. We’re talking about a safe, removable, long-lasting injection that takes away the burden of adhering to a daily medication regimen.”
Antiretroviral drugs are used in both prevention and treatment of HIV, and multiple types are used in combination to counteract resistance to any one antiretroviral drug. These drugs need to be taken consistently every day. There are many obstacles that stand in the way of adherence to these medication regimens. Benhabbour says this especially applies to otherwise healthy people trying to prevent infection.
“In sub-Saharan Africa where prevalence of HIV is highest, accessibility to these medications can be difficult, and there is much stigma associated with the virus,” Benhabbour said. “It is a very big deal for someone who doesn’t have HIV to go out of their way to not only access the drugs, but then associate themselves with HIV by taking a pill every day.”
There’s also the factor of human error. Anyone who strives to take a daily multivitamin can understand that some days the pill gets skipped, or gets taken at a different time of day. But such small deviations can make antiretroviral drugs less effective.
“Because one of the biggest difficulties associated with HIV prevention is lack of adherence to drug treatment, we wanted to create a drug delivery system that essentially solved this problem,” said senior author J. Victor Garcia, PhD, professor of medicine at UNC School of Medicine, director of the International Center for the Advancement of Translational Science and member of the UNC Center for AIDS Research.
The injectable implant is comprised of three elements – an organic solvent, a polymer, and the drug or drugs that need to be delivered. The formulation results in a honey-like liquid that turns into a solid when injected under the skin. This phase inversion happens when the solvent diffuses into the body leaving behind the polymer and medication(s) – the combination of which determines over what time period the medication(s) will be released into the blood system.
In this study six antiretroviral drugs were tested, and all kept their physical and chemical properties within the formulation and upon release. All six were also released from the implant at effective levels for a sustained amount of time ranging from one month to a year.
The injectable drug implant created by UNC’s research team is the first to address several drawbacks to the current method of long-acting drug delivery for HIV – namely the ability to remove it and quickly eliminate the presence of residual drug(s) in the system.
“If a patient needs to withdraw from the treatment because they’ve had a bad reaction to the drug(s), or maybe a woman has become pregnant, our implant can be easily surgically removed,” said Martina Kovarova, PhD, contributing author to the study and associate professor of medicine at UNC SOM.
This is the first ever injectable implant for HIV that can be removed as early as one week, or as late as months after the injection, and have drug levels virtually eliminated from the system within one week. If the implant does not need to be removed, it biodegrades into lactic and glycolic acids, which are already found in the body and are easily absorbed.
Researchers plan to continue developing and improving this multi-drug delivery system, observing its effects in relevant in vivo models and eventually humans.
The Latest on: Injectable multi-drug delivery system
via Google News
The Latest on: Injectable multi-drug delivery system
- Integrated approaches enable delivery of quality healthcare to all, says WHO experton January 19, 2020 at 8:33 pm
It has been observed that the use of injection in 95 per cent cases is unnecessary,” he said. On the universal health coverage, he said that everyone had to work jointly to achieve this target. The ...
- Injectable Drug Delivery Market World Approaching Demand and Growth Prospect 2020-2025on January 13, 2020 at 7:09 am
New York, January 13, 2020: The Global Injectable Drug Delivery Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and ...
- Injectable Drug Delivery Market 2020: Size, Share, Growth, Trends and Regional Forecast | Fortune Business Insights™on January 9, 2020 at 2:55 am
This further increases the adoption of injectable drug delivery systems. These manufacturers are planning to develop innovative drug delivery such as auto-injectors, smart wearables, among others in ...
- Ipsen Announces the Availability of the Newly Designed Delivery System for Somatuline® Autogel® (lanreotide injection)on January 7, 2020 at 5:37 am
MISSISSAUGA, ON, Jan. 7, 2020 /CNW/ - Ipsen Biopharmaceuticals Canada Inc. today announced the availability of a new delivery system for Somatuline ® Autogel ® (lanreotide injection) 60, 90, and 120 ...
- Injectable Drug Delivery Market 2020 - Global Growth Drivers and Regional Outlook to 2025on January 6, 2020 at 8:41 am
New York, January 06, 2020: The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled ...
- Injectable Implant Shows Promise In HIV Prevention & Treatmenton September 23, 2019 at 11:41 am
‘New long-term injectable implant addresses the issue of medication ... Researchers plan to continue developing and improving this multi-drug delivery system, observing its effects in relevant in vivo ...
- Long-Acting Injectable Multi-Drug Implant Shows Promise for HIV Prevention and Treatmenton September 22, 2019 at 12:42 pm
UNC researchers have created an injectable multi-drug delivery system that is removable, biodegradable and effective for up to a year in some cases. First author Rahima Benhabbour, PhD, MSc, says the ...
- Long-acting injectable multi-drug implant shows promise for HIV prevention and treatmenton September 20, 2019 at 10:22 am
UNC researchers have created an injectable multi-drug delivery system that is removable, biodegradable and effective for up to a year in some cases. The author says the ability to administer multiple ...
- How we 3D print your whole prescription into one pillon July 17, 2019 at 5:00 pm
Imagine that your whole multi-drug prescription arrived into a single ... are pharmaceutical polymers specifically designed for drug delivery. Multiply Labs’ robotic systems form the capsules, fill ...
- Self Administered Injectable Drug Delivery Systems: Products, Therapeutics, Markets, Players and Forecastson June 21, 2017 at 12:47 pm
LONDON, June 21, 2017 /PRNewswire/ -- Self Administered Injectable Drug Delivery Systems: Products, Therapeutics, Markets, Players and Forecasts is a comprehensive evaluation and analysis of the ...
via Bing News